Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Sarholz

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biometrical Journal. Biometrische Zeitschrift|November 28, 2008
Variance component estimation for mixed model analysis of cDNA microarray dataBarbara Sarholz, Hans-Peter Piepho
BMC Plant Biology|February 4, 2009
Validation of candidate genes putatively associated with resistance to SCMV and MDMV in maize (Zea mays L.) by expression profilingAnna Uzarowska, Giuseppe Dionisio, Barbara Sarholz, et al.
Japanese Journal of Clinical Oncology|April 25, 2020
Phase I trial of the MET inhibitor tepotinib in Japanese patients with solid tumorsKohei Shitara, Kentaro Yamazaki, Takahiro Tsushima, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|November 17, 2009
Heterosis in early seed development: a comparative study of F1 embryo and endosperm tissues 6 days after fertilizationStephanie Jahnke, Barbara Sarholz, Alexander Thiemann, et al.
Proteomics|August 16, 2008
Analysis of nonadditive protein accumulation in young primary roots of a maize (Zea mays L.) F(1)-hybrid compared to its parental inbred linesNadine Hoecker, Tobias Lamkemeyer, Barbara Sarholz, et al.
Targeted Oncology|September 9, 2014
Weekly and every 2 weeks cetuximab maintenance therapy after platinum-based chemotherapy plus cetuximab as first-line treatment for non-small cell lung cancer: randomized non-comparative phase IIIb NEXT trialDavid F Heigener, José Rodrigues Pereira, Enriqueta Felip, et al.
Leukemia & Lymphoma|April 26, 2021
Phase I, first-in-human trial of Bruton's tyrosine kinase inhibitor M7583 in patients with B-cell malignanciesWojciech Jurczak, Simon Rule, William Townsend, et al.
International Journal of Radiation Oncology, Biology, Physics|September 26, 2023
A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck TumorsMichael Samuels, Johan Falkenius, Voichita Bar-Ad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2023
A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal CancerPaul B Romesser, Jaume Capdevila, Rocio Garcia-Carbonero, et al.
British Journal of Cancer|November 24, 2020
A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumoursMark T J van Bussel, Ahmad Awada, Maja J A de Jonge, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biometrical Journal. Biometrische Zeitschrift|November 28, 2008
Variance component estimation for mixed model analysis of cDNA microarray dataBarbara Sarholz, Hans-Peter Piepho
BMC Plant Biology|February 4, 2009
Validation of candidate genes putatively associated with resistance to SCMV and MDMV in maize (Zea mays L.) by expression profilingAnna Uzarowska, Giuseppe Dionisio, Barbara Sarholz, et al.
Japanese Journal of Clinical Oncology|April 25, 2020
Phase I trial of the MET inhibitor tepotinib in Japanese patients with solid tumorsKohei Shitara, Kentaro Yamazaki, Takahiro Tsushima, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|November 17, 2009
Heterosis in early seed development: a comparative study of F1 embryo and endosperm tissues 6 days after fertilizationStephanie Jahnke, Barbara Sarholz, Alexander Thiemann, et al.
Proteomics|August 16, 2008
Analysis of nonadditive protein accumulation in young primary roots of a maize (Zea mays L.) F(1)-hybrid compared to its parental inbred linesNadine Hoecker, Tobias Lamkemeyer, Barbara Sarholz, et al.
Targeted Oncology|September 9, 2014
Weekly and every 2 weeks cetuximab maintenance therapy after platinum-based chemotherapy plus cetuximab as first-line treatment for non-small cell lung cancer: randomized non-comparative phase IIIb NEXT trialDavid F Heigener, José Rodrigues Pereira, Enriqueta Felip, et al.
Leukemia & Lymphoma|April 26, 2021
Phase I, first-in-human trial of Bruton's tyrosine kinase inhibitor M7583 in patients with B-cell malignanciesWojciech Jurczak, Simon Rule, William Townsend, et al.
International Journal of Radiation Oncology, Biology, Physics|September 26, 2023
A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck TumorsMichael Samuels, Johan Falkenius, Voichita Bar-Ad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2023
A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal CancerPaul B Romesser, Jaume Capdevila, Rocio Garcia-Carbonero, et al.
British Journal of Cancer|November 24, 2020
A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumoursMark T J van Bussel, Ahmad Awada, Maja J A de Jonge, et al.
Pageof 1